(Q35964140)
Statements
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients (English)
Elisavet Serti
Barbara Rehermann
Jonathan Stoltzfus
Birgit Edlich
Aintzane Zabaleta Azpiroz
Mazen Noureddin
Jordan J Feld
T Jake Liang
14 November 2011